LYON, France, April 22, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Atlantic Urology in Daytona Beach, Florida has received Institutional Review Board (IRB) approval to participate in EDAP’s ongoing ENLIGHT Phase II/III clinical trial of Ablatherm(r)-High Intensity Focused Ultrasound (HIFU) in patients with localized prostate cancer.
